AYU (An International Quarterly Journal of Research in Ayurveda)

CLINICAL RESEARCH
Year
: 2013  |  Volume : 34  |  Issue : 1  |  Page : 70--76

Efficacy of Virechana and Basti Karma with Shamana therapy in the management of essential hypertension: A comparative study


Gyanendra Shukla1, Santosh K Bhatted2, Alankruta R Dave3, Vageesha Datta Shukla4 
1 Lecturer, Department of Panchakarma, JD Ayurvedic Medical College and Hospital, Aligarh, Uttar Pradesh, India
2 Associate Professor, Department of Panchakarma, National Institute of Ayurveda, Jaipur, Rajasthan, India
3 Associate Professor and I/C Head, Department of Kaya Chikitsa, Institute for Post Graduate Teaching and Research in Ayurveda, Gujarat Ayurved University, Jamnagar, Gujarat, India
4 Professor, Department of Kaya Chikitsa, JS Patel Ayurved Mahavidyalaya, Nadiad, Gujarat, India

Correspondence Address:
Gyanendra Shukla
Lecturer, Department of Panchakarma, JD Ayurvedic Medical College and Hospital, Aligarh, Uttar Pradesh
India

Considering high prevalence and the need to look for alternative medicine, essential hypertension was screened in light of Vata-Pitta Pradhana Rakta Pradoshaja Vikara as mentioned by Acharya Charaka. Comparing the etiological factors, symptomatology, and complications with Rakta Pradoshaja Vikara with that of essential hypertension, a striking similarity was revealed. To prove the practical approach of management of Vata-Pitta Pradhana Rakta Pradoshaja Vikara, a randomized open clinical trial on 33 uncomplicated subjects of essential hypertension was conducted. The subjects were allotted in two groups, viz. (Group A) Virechana group having 16 cases who underwent Virechana Karma by Trivrita, Aragvadha, Eranda Taila, and Draksha Kwatha as Sahapana; and (Group B) Basti group consisting of 17 cases who were administered Dashmoola Kala Basti in which Niruha with Dashmoola Kwatha and Anuvasana with Dashmoola Taila was done. Patients of both the groups were followed by Shamana Chikitsa (Arjunadi Ghanavati). The overall effect of the therapies on systolic and diastolic blood pressure showed that Virechana proved better relief (43.75%) as compared to Basti (29.41%). The response was encouraging and has created scope for further studies.


How to cite this article:
Shukla G, Bhatted SK, Dave AR, Shukla VD. Efficacy of Virechana and Basti Karma with Shamana therapy in the management of essential hypertension: A comparative study.AYU 2013;34:70-76


How to cite this URL:
Shukla G, Bhatted SK, Dave AR, Shukla VD. Efficacy of Virechana and Basti Karma with Shamana therapy in the management of essential hypertension: A comparative study. AYU [serial online] 2013 [cited 2021 Jan 26 ];34:70-76
Available from: https://www.ayujournal.org/article.asp?issn=0974-8520;year=2013;volume=34;issue=1;spage=70;epage=76;aulast=Shukla;type=0